Rocket Pharmaceuticals Inc (RCKT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $256.82M
Last updated: Nov 17, 2026 at 11:06 AM ET
Rocket Pharmaceuticals Inc (RCKT) Earnings: Report Dates and Results
Rocket Pharmaceuticals (RCKT) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Rocket Pharmaceuticals reported EPS of -$0.43, below the -$0.39 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
RCKT has an expected report date of Feb 24, 2027.
Earnings History
Of the 39 quarters below that had an estimate, RCKT beat 23, missed 15 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2026, when EPS landed 153.57% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.43 | -$0.39 | -$0.43 - -$0.35 | -10.26% | Miss | N/A | 5 | 2 up, 1 down | Nov 12, 2026 |
| Jun 30, 2026 | -$0.15 | $0.28 | -$0.54 - $1.15 | -153.57% | Miss | N/A | 8 | 2 up, 1 down | Aug 10, 2026 |
| Mar 31, 2026 | -$0.42 | -$0.43 | -$0.52 - -$0.39 | +2.33% | Beat | N/A | 5 | 1 up, 0 down | May 7, 2026 |
| Dec 31, 2025 | -$0.38 | -$0.42 | -$0.56 - -$0.31 | +9.52% | Beat | N/A | 11 | 3 up, 4 down | Feb 26, 2026 |
| Sep 30, 2025 | -$0.45 | -$0.52 | -$0.60 - -$0.38 | +13.46% | Beat | N/A | 14 | 1 up, 1 down | Nov 6, 2025 |
| Jun 30, 2025 | -$0.59 | -$0.57 | -$0.60 - -$0.15 | -3.51% | Miss | N/A | 16 | 1 up, 0 down | Aug 7, 2025 |
| Mar 31, 2025 | -$0.56 | -$0.58 | -$0.82 - -$0.23 | +3.45% | Beat | N/A | 13 | 2 up, 0 down | May 8, 2025 |
| Dec 31, 2024 | -$0.62 | -$0.72 | -$0.80 - -$0.62 | +13.64% | Beat | N/A | 13 | 2 up, 0 down | Feb 27, 2025 |
| Sep 30, 2024 | -$0.71 | -$0.75 | -$0.84 - -$0.65 | +5.33% | Beat | N/A | 15 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$0.74 | -$0.72 | -$0.82 - -$0.57 | -2.78% | Miss | N/A | 14 | 1 up, 0 down | Aug 5, 2024 |
| Mar 31, 2024 | -$0.66 | -$0.68 | -$0.83 - -$0.50 | +2.94% | Beat | N/A | 12 | 0 up, 0 down | May 6, 2024 |
| Dec 31, 2023 | -$0.64 | -$0.77 | -$0.89 - -$0.67 | +16.88% | Beat | N/A | 12 | 1 up, 0 down | Feb 26, 2024 |
| Sep 30, 2023 | -$0.75 | -$0.78 | -$0.93 - -$0.65 | +3.85% | Beat | N/A | 12 | 0 up, 0 down | Nov 6, 2023 |
| Jun 30, 2023 | -$0.82 | -$0.78 | -$0.88 - -$0.68 | -5.13% | Miss | N/A | 10 | 0 up, 0 down | Aug 10, 2023 |
| Mar 31, 2023 | -$0.73 | -$0.85 | -$0.96 - -$0.75 | +14.12% | Beat | N/A | 12 | 0 up, 0 down | May 4, 2023 |
| Dec 31, 2022 | -$0.89 | -$0.82 | -$1.00 - -$0.56 | -8.54% | Miss | N/A | 14 | 0 up, 0 down | Feb 27, 2023 |
| Sep 30, 2022 | -$0.87 | -$0.77 | -$0.90 - -$0.68 | -12.99% | Miss | N/A | 13 | 0 up, 0 down | Nov 3, 2022 |
| Jun 30, 2022 | -$0.83 | -$0.68 | -$0.76 - -$0.59 | -22.06% | Miss | N/A | 12 | 0 up, 0 down | Aug 8, 2022 |
| Mar 31, 2022 | -$0.67 | -$0.71 | -$0.79 - -$0.63 | +5.63% | Beat | N/A | 10 | 1 up, 0 down | May 5, 2022 |
| Dec 31, 2021 | -$0.69 | -$0.73 | -$1.10 - -$0.66 | +5.48% | Beat | N/A | 11 | 0 up, 0 down | Feb 24, 2022 |
| Sep 30, 2021 | -$0.79 | -$0.62 | -$0.68 - -$0.56 | -27.42% | Miss | N/A | 11 | 8 up, 0 down | Nov 3, 2021 |
| Jun 30, 2021 | -$0.55 | -$0.65 | -$0.75 - -$0.54 | +15.38% | Beat | N/A | 11 | N/A | Aug 9, 2021 |
| Mar 31, 2021 | -$0.65 | -$0.69 | -$1.01 - -$0.51 | +5.80% | Beat | N/A | 11 | N/A | May 10, 2021 |
| Dec 31, 2020 | -$1.08 | -$0.50 | -$0.57 - -$0.44 | -116.00% | Miss | N/A | 13 | N/A | Feb 25, 2021 |
| Sep 30, 2020 | -$0.53 | -$0.45 | -$0.51 - -$0.42 | -17.78% | Miss | N/A | 11 | N/A | Nov 4, 2020 |
| Jun 30, 2020 | -$0.45 | -$0.50 | -$0.77 - -$0.42 | +10.00% | Beat | N/A | 9 | N/A | Aug 5, 2020 |
| Mar 31, 2020 | -$0.45 | -$0.45 | -$0.85 - -$0.38 | 0.00% | In line | N/A | 8 | N/A | May 6, 2020 |
| Dec 31, 2019 | -$0.39 | -$0.49 | -$0.69 - -$0.40 | +20.41% | Beat | N/A | 8 | N/A | Mar 5, 2020 |
| Sep 30, 2019 | -$0.38 | -$0.51 | -$0.75 - -$0.39 | +25.49% | Beat | N/A | 9 | N/A | Nov 7, 2019 |
| Jun 30, 2019 | -$0.38 | -$0.61 | -$0.61 - -$0.40 | +37.70% | Beat | N/A | 7 | N/A | Aug 7, 2019 |
| Mar 31, 2019 | -$0.43 | -$0.62 | -$0.72 - -$0.49 | +30.65% | Beat | N/A | 7 | N/A | May 8, 2019 |
| Dec 31, 2018 | -$0.66 | -$0.44 | -$0.51 - -$0.40 | -50.00% | Miss | N/A | 5 | N/A | Mar 7, 2019 |
| Sep 30, 2018 | -$0.40 | -$0.44 | -$0.50 - -$0.38 | +9.09% | Beat | N/A | 3 | N/A | Nov 7, 2018 |
| Jun 30, 2018 | -$0.40 | -$0.44 | -$0.44 - -$0.29 | +9.09% | Beat | N/A | 2 | N/A | Aug 8, 2018 |
| Mar 31, 2018 | -$0.28 | -$0.39 | N/A | +28.21% | Beat | N/A | N/A | N/A | May 11, 2018 |
| Dec 31, 2017 | -$0.72 | -$0.31 | N/A | -132.26% | Miss | N/A | N/A | N/A | Mar 7, 2018 |
| Sep 30, 2017 | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 8, 2017 |
| Jun 30, 2017 | -$0.96 | -$1.88 | N/A | +48.94% | Beat | N/A | N/A | N/A | Aug 3, 2017 |
| Mar 31, 2017 | -$1.60 | -$1.57 | N/A | -1.91% | Miss | N/A | N/A | N/A | May 10, 2017 |
| Dec 31, 2016 | -$1.92 | -$1.73 | N/A | -10.98% | Miss | N/A | N/A | N/A | Mar 16, 2017 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.98, after -$2.73 the year before. It was -$6.40 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.98 | N/A |
| Dec 31, 2024 | -$2.73 | N/A |
| Dec 31, 2023 | -$2.94 | N/A |
| Dec 31, 2022 | -$3.26 | N/A |
| Dec 31, 2021 | -$2.68 | N/A |
| Dec 31, 2020 | -$2.51 | N/A |
| Dec 31, 2019 | -$1.58 | N/A |
| Dec 31, 2018 | -$1.74 | N/A |
| Dec 31, 2017 | -$3.55 | N/A |
| Dec 31, 2016 | -$6.40 | N/A |
Frequently Asked Questions About RCKT
When is Rocket Pharmaceuticals's next earnings date?
Rocket Pharmaceuticals's next earnings report is expected for Feb 24, 2027.
Did RCKT beat earnings estimates last quarter?
No. Rocket Pharmaceuticals reported EPS of -$0.43 for the quarter ended Sep 30, 2026, below the -$0.39 estimate by 10.26%.
What EPS do analysts expect from RCKT next quarter?
The consensus EPS estimate for Rocket Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.42 from 15 analysts, with estimates from -$0.45 to -$0.25.
How often does RCKT beat earnings estimates?
Rocket Pharmaceuticals beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -15.62%.
RCKT pages: Overview, Earnings, Forecast, Financials, Competitors